한빛사논문
St. Jude Children’s Research Hospital, 현 우석대학교
Joo-Hui Han 1,5,8, Rajendra Karki 1,6,8, R. K. Subbarao Malireddi 1, Raghvendra Mall 1,7, Roman Sarkar 1, Bhesh Raj Sharma 1, Jonathon Klein 2, Harmut Berns 2, Harshan Pisharath 3, Shondra M. Pruett-Miller 2, Sung-Jin Bae 4 & Thirumala-Devi Kanneganti 1,*
1Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.
2Center for Advanced Genome Engineering, St Jude Children’s Research Hospital, Memphis, TN 38105, USA.
3Animal Resources Center, St Jude Children’s Research Hospital, Memphis, TN 38105, USA.
4Department of Molecular Biology and Immunology, College of Medicine, Kosin University, Busan 49267, Republic of Korea.
5Present address: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Woosuk University, Wanju 55338, Republic of Korea.
6Present address: Department of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea.
7Present address: Biotechnology Research Center, Technology Innovation Institute, Abu Dhabi, P.O. Box 9639, United Arab Emirates.
8These authors contributed equally: Joo-Hui Han, Rajendra Karki.
*Corresponding author: correspondence to Thirumala-Devi Kanneganti
Abstract
Innate immunity provides the first line of defense through multiple mechanisms, including pyrogen production and cell death. While elevated body temperature during infection is beneficial to clear pathogens, heat stress (HS) can lead to inflammation and pathology. Links between pathogen exposure, HS, cytokine release, and inflammation have been observed, but fundamental innate immune mechanisms driving pathology during pathogen exposure and HS remain unclear. Here, we use multiple genetic approaches to elucidate innate immune pathways in infection or LPS and HS models. Our results show that bacteria and LPS robustly increase inflammatory cell death during HS that is dependent on caspase-1, caspase-11, caspase-8, and RIPK3 through the PANoptosis pathway. Caspase-7 also contributes to PANoptosis in this context. Furthermore, NINJ1 is an important executioner of this cell death to release inflammatory molecules, independent of other pore-forming executioner proteins, gasdermin D, gasdermin E, and MLKL. In an in vivo HS model, mortality is reduced by deleting NINJ1 and fully rescued by deleting key PANoptosis molecules. Our findings suggest that therapeutic strategies blocking NINJ1 or its upstream regulators to prevent PANoptosis may reduce the release of inflammatory mediators and benefit patients.
논문정보